IRCT20220211053992N21招募中Unknown
In vivo Bioequivalence study of Hydrochlorothiazide 25 mg tablet manufactured by AaniDarman Pharmaceutical Co. Compared to innovator Product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 59 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
已完成
不适用
Bio equivalence study of Hydrochlorothiazide 50 mg tabletsIRCT20200513047423N4Fatak Chemie Pars24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Hydrochlorothiazide 50 mg Tablet formulations.IRCT20180620040164N51Karen Pharma and Food Supplement Co.24
进行中（未招募）
不适用
Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg MonotherapyEssential hypertensionMedDRA version: 8.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2006-003876-37-CZDAIICHI SANKYO EUROPE GmbH2,220
进行中（未招募）
1 期
Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg MonotherapyEficacia y seguridad de Hidroclorotiazida, utilizada como terapia adicional, en pacientes con hipertensión moderada a severa no controlados adecuadamente con Olmesartan MEdoxomil 40 mg en monoterapiaEssential hypertensionHipertensión esencialMedDRA version: 8.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2006-003876-37-ESDAIICHI SANKYO EUROPE GmbH1,500
进行中（未招募）
不适用
Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg MonotherapyEssential hypertensionMedDRA version: 8.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2006-003876-37-DEDAIICHI SANKYO EUROPE GmbH1,500